First, inject virus into a mouse. Lymphocytes in mouse produce complimentary antibodies. Then, lymphocytes combine with a tumour cell to form a hybridoma. The hybridoma produces monoclonal antibodies specific to virus. This is cloned to produce a lot of antibodies ready to treat patients